Literature DB >> 23235278

[A case of long-term survivor after combined modality therapy for brain metastasis of bladder carcinoma].

Kengo Yasuda1, Masafumi Nakamura, Daiji Takamoto, Hiroyuki Sanjo, Ayako Gohbara, Jun-ichi Teranishi, Yasushi Yumura, Yasuhide Miyoshi, Keiichi Kondo, Kazumi Noguchi, Yoshinobu Kubota.   

Abstract

A 75-year-old man with advanced bladder cancer (cT4N1M0) received three courses of systemic chemotherapy with Methotrexate, Epirubicin and Nedaplatin (MEN). His metastatic lymph node completely disappeared. We performed total cystectomy. Three months after the surgery, he complained of neck pain and nausea. Brain magnetic resonance imaging (MRI) revealed a 3 cm tumor in his right cerebella and a 5 mm tumor in left parietal lobe. He underwent surgical resection of the right cerebellar tumor and a gamma knife therapy for the left parietal tumor. Pathological diagnosis was metastatic urothelial carcinoma. We performed three additional courses of chemotherapy of MEN. He has been well without local recurrence or distant metastasis for 18 months.

Entities:  

Mesh:

Year:  2012        PMID: 23235278

Source DB:  PubMed          Journal:  Hinyokika Kiyo        ISSN: 0018-1994


  1 in total

1.  Metastatic brain tumor from urothelial carcinoma of the prostatic urethra.

Authors:  Kohei Morita; Masashi Oda; Masaomi Koyanagi; Masaaki Saiki
Journal:  Surg Neurol Int       Date:  2016-07-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.